Yahoo奇摩 網頁搜尋

  1. 勞保借款 相關

    廣告
  2. 小資人生不打結!專人詳細諮詢,精算個人化利率與額度,專屬申貸試算一站搞定,即刻申辦! 快速實現旅遊夢想!方案靈活不求人,有錢過難關,開心少負擔,五分鐘為幸福鋪路,馬上諮詢!

  3. "現主時"貸給您投資理財、債務整合、購車買房、結婚遊學等資金周轉. 軍公教、醫療人員、上市櫃公司貸款專案,信貸、房貸、車貸一次解決 !

搜尋結果

  1. ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. ...

  2. Our new 2024 ArisGlobal Industry Report, Life Sciences R&D Transformation: Ambitions for Intelligent Automation & Today’s Reality, provides a timely deep-dive into the findings of our latest AI & Automation Industry Survey. The research was conducted in late 2023 with 80+ organizations, spanning every patient treatment process domain, from ...

  3. China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software

  4. Speed. Quality. Collaboration. Delivered in One Simple Unified Platform. LifeSphere Regulatory Affairs software delivers end-to-end regulatory information management in an all-new, fully unified cloud platform that accelerates speed to market, enhances data quality and streamlines collaboration across teams.

  5. Uncategorized: Pharmacovigilance in China Current Updates, Challenges and Solutions for the Industry. The Chinese Federal Drug Authority (CFDA) regulations are changing and that brings both challenges and opportunities. The introduction of the E2B (R3) mandate pushed the local Chinese pharmaceutical market to scramble.

  6. Miami, Florida, Tokyo, August 23, 2021 Asahi Kasei Pharma Corp. has selected LifeSphere® MultiVigilance as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term. In addition, Asahi Kasei Pharma will adopt ArisGlobal’s rapid migration methodology, which has been successfully embraced by […]

  7. 2024年4月23日 · New Generative AI Council to Advance Life Sciences Innovation, ArisGlobal Launches GenAI Council with Top Minds from Pharma, Academia, and Technology. Group announces inaugural session as well as its charter — to advance the use of GenAI in life sciences R&D…. Learn More. Press Release. Dec 14, 2023.

  1. 其他人也搜尋了